Adaptimmune Therapeutics PLC American...





After Hours:




Please Login or Register

Login|Register FREE

Stock Price
Open: 11.10
Prev. Close: 10.94
Low/Hi: 10.51 - 11.55
52-Week: 3.90 - 13.41
Equity: 1,374,786
90-Day Avg: 438,961
Option: 257
90-Day Avg: 86
Todays Stock Vol: 98.2
20-Day (HV): 69.7
52-Week (HV): 67.6
30-Day IV: 85.2 -1.7
IV Pct Rank: 97% Elevated
Div. Yield:
Earnings: 11-May (Est.)
P/E Ratio:
Market Cap: 1.0 B
Short Int Pct: 0.0%
Pct Held By Inst.: 55.3%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ADAP

Adaptimmune is a clinical stage biopharmaceutical company focused on novel cancer immunotherapy products based on its T-cell receptor platform. Established in 2008, the Company aims to utilize the bodys own machinery - the T-cell - to target and destroy cancer cells by using engineered, increased affinity T-cell receptors (TCRs) as a means of strengthening natural patient T-cell responses. Adaptimmunes lead program is an affinity enhanced TCR therapeutic targeting the NY-ESO cancer antigen. Its NY-ESO TCR therapeutic candidate has demonstrated signs of efficacy and tolerability in Phase 1/2 trials in solid tumors and in hematologic cancer types. As of June 30, 2015, 85 patients had been treated with Adaptimmunes NY-ESO TCR therapeutic: 47 under Adaptimmunes IND, and 38 under a National Cancer Institute IND. In June 2014, Adaptimmune announced that it had entered into a strategic collaboration and licensing agreement with GlaxoSmithKline for the development and commercialization of the NY-ESO TCR program. The Company currently has over 150 employees.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ADAP is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 417.7 M 4.17656E+08 204 204 0.04% 0.00035269 323 K 323014
IBB iShares Nasdaq Biotechnology Index Fund 9.5 B 9.54165E+09 193 193 0.08% 0.0008 7.7 M 7662250
SBIO ALPS Medical Breakthroughs ETF 184.6 M 1.84551E+08 96 96 0.76% 0.0076 1.4 M 1402588
UBIO Proshares UltraPro Nasdaq Biotechnology 41.6 M 4.16428E+07 198 198 0.02% 0.000217951 30 K 29549

Wait, Before You Leave...

Want to Know More About ADAP Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon